LENZ Therapeutics, Inc.
LENZ
$38.63
-$1.06-2.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.00% | -15.55% | -23.86% | 0.38% | 38.41% |
| Total Depreciation and Amortization | -47.22% | 44.00% | 150.00% | -44.44% | 260.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.21% | 577.03% | -73.32% | 30.41% | -62.89% |
| Change in Net Operating Assets | 148.10% | -189.24% | 375.41% | 80.51% | 31.24% |
| Cash from Operations | 28.29% | -76.79% | 14.20% | 33.01% | 34.01% |
| Capital Expenditure | -118.18% | 26.17% | 19.89% | -39.85% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.92% | 262.19% | 81.12% | 36.86% | -645.87% |
| Cash from Investing | -102.19% | 259.23% | 80.94% | 36.76% | -646.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 60,100.00% | -16.98% | -99.82% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 99.35% | -101.69% |
| Cash from Financing | 60,100.00% | -16.98% | -99.82% | 1,495.32% | -101.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 405.06% | 113.81% | 51.41% | 63.04% | -170.36% |